Just In: Canary Capital Files For First Injective ETF, INJ Price Up
Highlights
- Canary Capital has filed an Injective ETF application with the SEC.
- The fund manager is eyeing staking functionality in the INJ ETF.
- INJ price is trading at $13.92, gaining an impressive 4.3% in a day.
Canary Capital has made history with the filing of the first-ever staked Injective exchange-traded fund (ETF) with the US Securities and Exchange Commission (SEC). The INJ price surged as much as 5% amid this development, providing a bullish outlook for the altcoin.
Canary Capital Eyes Injective ETF Approval
According to a SEC filing, Investment fund Canary Capital is seeking the SEC’s approval for an Injective ETF. Canary Capital’s filing is the pioneering attempt to offer investors regulated exposure to staked INJ via an ETF.
Dubbed the Canary Staked INJ ETF, the filing comes amid heightened institutional interest in Injective, a layer one blockchain built for DeFi applications. Key technology players, including Google Cloud and T-Mobile, have joined the Injective Council.
“The proposed Canary ETF would provide retail and institutional investors with direct exposure to staked INJ through a regulated investment vehicle, effectively bridging the gap between traditional and on-chain finance,” read an official statement from Injective.
Rather than merely holding INJ tokens, the proposed ETF will seek to deploy the tokens in Injective’s proof-of-stake consensus mechanism.
1/ History is being made today!
Canary Capital just filed the first US Staked $INJ ETF with the SEC, giving institutions and everyday investors a regulated path to access the native Injective token through traditional brokerages and banking rails.
Here’s why it’s a big deal 🧵 pic.twitter.com/GkLtkR41N1
— Injective 🥷 (@injective) July 17, 2025
Amid the filing, INJ price rallied by nearly 5% to trade at $13.92 while daily trading volumes spiked by 3.95%. It is worth noting that Canary Capital had previously registered a statutory trust for a staked Injective ETF in Delaware, hinting at plans to offer this fund.
With the fund incorporation and S-1 filing out of the way, an exchange is expected to file the 19b-4 form to list and trade shares of the Injective. This would officially kickstart the approval process.
Canary Capital has already filed for XRP and SOL ETFs with the US SEC. Early in the week, the CEO of Canary Capital predicted that XRP ETFs would outperform ETH and SOL ETFs, citing regulatory clarity and positive adoption metrics.
- Ripple Eyes Tokenization and Stablecoins in XRP Ledger Institutional DeFi Roadmap
- UK and US Announce Joint Task force to Boost Collaboration on Crypto Regulation
- Deutsche Bank Predicts Central Banks Could Adopt Bitcoin Alongside Gold by 2030
- Bitget’s Universal Exchange Merges Crypto, Stocks, and RWAs To Offer Global Market Access
- PancakeSwap Launches Crosschain Swaps on Solana Amid Aster DEX Competition
- Solana Price Prediction: $836M Whale Transfer Spark Fear of $200 Retest Before 62% Rebound
- Bitcoin Price Prediction: $150K in Q4 as Gold’s ATH Momentum Sets the Tone
- PUMP Price Forecast: Whale Buys 1B Tokens as Bullish Pennant Signals 65% Breakout
- Bitcoin Price Prediction: Analyst Highlights Breakout Patterns as Coinbase CEO Backs Crypto Structure Bill
- Dogecoin Price Prediction: Grayscale ETF Move Aligns With Cycle Breakout
- Chainlink Price Prediction: Whales Scoop 2M LINK as Analysts Eye 184% Breakout Rally
Why Trust CoinGape
CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights Read more…to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.
